Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Short Communication
  • Published:

Proof-of-concept for a virus-induced obesity vaccine; vaccination against the obesity agent adenovirus 36

International Journal of Obesity volume 38, pages 1470–1474 (2014)Cite this article

Subjects

Abstract

Human adenovirus 36 (Ad36) is positively associated with obesity in humans and animals. Ad36 infection is characterized by increased adiposity and inflammation. To investigate the possibility that a prophylactic vaccine candidate might protect against Ad36-induced obesity and inflammation, we purified Ad36 and ultraviolet-irradiated virus to obtain a vaccine candidate. After immunizing the mice with the vaccine candidate (vaccinated group), live Ad36 was injected into mice as a challenge test. Unvaccinated mice (control group) were immunized with phosphate-buffered saline and then challenged with live Ad36. Fourteen weeks after challenge, we compared adiposity and inflammation in vaccinated and control mice. The control group showed 17% greater body weight and 20% more epididymal fats compared with the vaccinated group. In addition, the vaccinated group had decreased serum levels of pro-inflammatory cytokines, and infiltrated immune cells, especially M1 macrophages, in fat tissue. Therefore, the vaccine candidate for Ad36 was able to protect against Ad36-increased body weight and fat as well as inflammatory states after challenge. These results provide proof-of-concept for prophylactic vaccination against virus-induced adiposity.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2

Similar content being viewed by others

References

  1. Reaven GM . All obese individuals are not created equal: insulin resistance is the major determinant of cardiovascular disease in overweight/obese individuals. Diab Vasc Dis Res 2005; 2: 105–112.

    Article  Google Scholar 

  2. Hainer V . Comparative efficiency and safety of pharmacological approaches to the management of obesity. Diabetes Care 2011; 34: S349–S354.

    Article  Google Scholar 

  3. Atkinson RL, Dhurandhar NV, Allison DB, Bowen RL, Israel BA, Augustus AS et al. Human adenovirus-36 is associated with increased body weight and paradoxical reduction of serum lipids. Int J Obes (Lond) 2005; 29: 281–286.

    Article  CAS  Google Scholar 

  4. Dhurandhar NV, Israel BA, Kolesar JM, Mayhew GF, Cook ME, Atkinson RL . Increased adiposity in animals due to a human virus. Int J Obes Relat Metab Disord 2000; 24: 989–996.

    Article  CAS  Google Scholar 

  5. Dhurandhar NV, Whigham LD, Abbott DH, Schultz-Darken NJ, Israel BA, Atkinson RL et al. Human adenovirus Ad-36 promotes weight gain in male rhesus and marmoset monkeys. J Nutr 2002; 132: 3155–3160.

    Article  CAS  Google Scholar 

  6. Na HN, Nam JH . Adenovirus 36 as an obesity agent maintains the obesity state by increasing MCP-1 and inducing inflammation. J Infect Dis 2012; 205: 914–922.

    Article  CAS  Google Scholar 

  7. Tollefson AE, Kuppuswamy M, Shashkova EV, Doronin K, Wold WS . Preparation and titration of CsCl-banded adenovirus stocks. Methods Mol Med 2007; 130: 223–235.

    CAS  PubMed  Google Scholar 

  8. Pasarica M, Loiler S, Dhurandhar NV . Acute effect of infection by adipogenic human adenovirus Ad36. Arch Virol 2008; 153: 2097–2102.

    Article  CAS  Google Scholar 

  9. Lumeng CN, Saltiel AR . Inflammatory links between obesity and metabolic disease. J Clin Invest 2011; 121: 2111–2117.

    Article  CAS  Google Scholar 

  10. Sun S, Ji Y, Kersten S, Qi L . Mechanisms of inflammatory responses in obese adipose tissue. Annu Rev Nutr 2012; 32: 261–286.

    Article  CAS  Google Scholar 

  11. Na HN, Kim J, Lee HS, Shim KW, Kimm H, Nam JH et al. Association of human adenovirus-36 in overweight Korean adults. Int J Obes (Lond) 2012; 36: 281–285.

    Article  CAS  Google Scholar 

  12. Trovato GM, Castro A, Tonzuso A, Garozzo A, Martines GF, Catalano D et al. Human obesity relationship with Ad36 adenovirus and insulin resistance. Int J Obes (Lond) 2009; 33: 1402–1409.

    Article  CAS  Google Scholar 

  13. Raviv Y, Viard M, Bess JW, Chertova E, Blumenthal R . Inactivation of retroviruses with preservation of structural integrity by targeting the hydrophobic domain of the viral envelope. J Virol 2005; 79: 12394–12400.

    Article  CAS  Google Scholar 

  14. Krishnapuram R, Dhurandhar EJ, Dubuisson O, Kirk-Ballard H, Bajpeyi S, Butte N et al. Template to improve glycemic control without reducing adiposity or dietary fat. Am J Physiol Endocrinol Metab 2011; 300: E779–E789.

    Article  CAS  Google Scholar 

  15. Trovato GM, Martines GF, Trovato FM, Pirri C, Pace P, Garozzo A et al. Adenovirus-36 seropositivity enhances effects of nutritional intervention on obesity, bright liver, and insulin resistance. Dig Dis Sci 2012; 57: 535–544.

    Article  CAS  Google Scholar 

  16. Laing EM, Tripp RA, Pollock NK, Baile CA, Della-Fera MA, Rayalam S et al. Adenovirus 36, adiposity, and bone strength in late-adolescent females. J Bone Miner Res 2013; 28: 489–496.

    Article  Google Scholar 

  17. Dhurandhar NV . Insulin sparing action of adenoirus 36 and its E4orf1 protein. J Diabetes Complications 2013; 27: 191–199.

    Article  Google Scholar 

  18. Choi Y, Chang J . Viral vectors for vaccine applications. Clin Exp Vaccine Res 2013; 2: 97–105.

    Article  CAS  Google Scholar 

  19. Burchill MA, Tamburini BA, Pennock ND, White JT, Kurche JS, Kedl RM . T cell vaccinology: exploring the known unknowns. Vaccine 2013; 31: 297–305.

    Article  CAS  Google Scholar 

  20. Lee SG, Jin JY, Kwon BM, Park SW, Paik SY . Inactivation of 2009 pandemic human influenza A virus H1N1 by photocatalyst under UV irradiation. J Bac Virol 2012; 42: 83–85.

    Article  CAS  Google Scholar 

Download references

Acknowledgements

This work was supported by a grant from the GRRC of the Catholic University of Korea and by the Basic Science Research Program of the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science and Technology (2012R1A1A2039819).

Author information

Authors and Affiliations

  1. Department of Biotechnology, The Catholic University of Korea, Bucheon, Korea

    H-N Na & J-H Nam

Authors
  1. H-N Na
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. J-H Nam
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to J-H Nam.

Ethics declarations

Competing interests

The authors declare no conflict of interest.

Additional information

Supplementary Information accompanies this paper on International Journal of Obesity website

Supplementary information

Rights and permissions

Reprints and permissions

About this article

Cite this article

Na, HN., Nam, JH. Proof-of-concept for a virus-induced obesity vaccine; vaccination against the obesity agent adenovirus 36. Int J Obes 38, 1470–1474 (2014). https://doi.org/10.1038/ijo.2014.41

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/ijo.2014.41

Keywords

This article is cited by

Search

Advanced search

Quick links